A Case of Uveitis in a Patient With Juvenile Myelomonocytic Leukemia Successfully Treated With Adalimumab.

Journal of Pediatric Hematology/oncology
Luisa Cortellazzo WielAlberto Tommasini

Abstract

Patients with juvenile myelomonocytic leukemia due to germline CBL mutation (10% to 15%) may have a subacute course occasionally associated with autoimmune disorders, which may resemble RAS-associated autoimmune lymphoproliferative disorder. In both conditions, prognosis and standard treatment for autoimmune phenomena remain poorly understood. We report the case of a 7-year-old boy with juvenile myelomonocytic leukemia with severe steroid-dependent uveitis, who did not respond to several therapeutic attempts with immunosuppressant agents, including sirolimus, and was finally successfully treated with adalimumab. This case offers further insight into the management of autoimmune disorders in the context of predisposing genetic conditions.

References

Nov 2, 2005·Pediatric Blood & Cancer·Jennifer O LauchleKevin Shannon
Jul 3, 2009·Blood·Mignon L LohCharlotte M Niemeyer
Mar 17, 2015·Translational Vision Science & Technology·Mohamed A IbrahimQuan Dong Nguyen
Feb 26, 2016·Journal of Human Genetics·Michiko MuraokaAkira Shimada
Jan 4, 2017·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Robert J RagotteStuart E Turvey
Apr 18, 2017·European Journal of Medical Genetics·Rachel R CoeClara D M van Karnebeek
Jun 17, 2018·Clinical and Experimental Dermatology·A GiacamanA Martín-Santiago

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.